These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17854036

  • 1. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM, Chabay PA, Valva P, Stefanoff CG, Barros MH, De Matteo E, Renault IZ, Preciado MV, Hassan R.
    J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
    [Abstract] [Full Text] [Related]

  • 2. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P, De Matteo E, Merediz A, Preciado MV.
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [Abstract] [Full Text] [Related]

  • 3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [Abstract] [Full Text] [Related]

  • 4. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [Abstract] [Full Text] [Related]

  • 5. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR, Lin Q, Wu XY.
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [Abstract] [Full Text] [Related]

  • 6. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, Greiner TC.
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [Abstract] [Full Text] [Related]

  • 7. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
    Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF.
    Oncogene; 1995 Feb 02; 10(3):523-8. PubMed ID: 7845677
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ.
    Oncogene; 1996 Sep 05; 13(5):947-53. PubMed ID: 8806684
    [Abstract] [Full Text] [Related]

  • 13. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H, Martius F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt BF.
    Leukemia; 1995 Mar 05; 9(3):458-65. PubMed ID: 7885044
    [Abstract] [Full Text] [Related]

  • 14. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
    Correa RM, Fellner MD, Alonio LV, Durand K, Teyssié AR, Picconi MA.
    J Med Virol; 2004 Aug 05; 73(4):583-8. PubMed ID: 15221903
    [Abstract] [Full Text] [Related]

  • 15. Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.
    Berger C, van Baarle D, Kersten MJ, Klein MR, Al-Homsi AS, Dunn B, McQuain C, van Oers R, Knecht H.
    J Infect Dis; 1999 Jan 05; 179(1):240-4. PubMed ID: 9841847
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM.
    J Med Virol; 2002 Nov 05; 68(3):370-7. PubMed ID: 12226824
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P.
    Br J Cancer; 2001 May 04; 84(9):1227-34. PubMed ID: 11336475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and A and B viruses strains].
    Trimeche M, Korbi S, Ziadi S, Amara K, Boniver J, de Leval L.
    Ann Biol Clin (Paris); 2005 May 04; 63(2):193-9. PubMed ID: 15771977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.